According to CONMED's latest financial reports the company has a price-to-book ratio of 2.62.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 4.04 | 11.39% |
2022-12-31 | 3.62 | -31.34% |
2021-12-31 | 5.28 | 16.84% |
2020-12-31 | 4.52 | 0.99% |
2019-12-31 | 4.47 | 64.05% |
2018-12-31 | 2.73 | 20.94% |
2017-12-31 | 2.25 | 6.52% |
2016-12-31 | 2.12 | 1.47% |
2015-12-31 | 2.09 | -2.11% |
2014-12-31 | 2.13 | 10.24% |
2013-12-31 | 1.93 | 47.98% |
2012-12-31 | 1.31 | 4.47% |
2011-12-31 | 1.25 | -1.66% |
2010-12-31 | 1.27 | 10.31% |
2009-12-31 | 1.15 | -10.37% |
2008-12-31 | 1.29 | -1.81% |
2007-12-31 | 1.31 | -10.84% |
2006-12-31 | 1.47 | -0.22% |
2005-12-31 | 1.47 | -19.91% |
2004-12-31 | 1.84 | 15.06% |
2003-12-31 | 1.60 | 9.7% |
2002-12-31 | 1.46 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.11 | 94.64% | ๐บ๐ธ USA |
Medtronic MDT | 2.02 | -22.92% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 5.07 | 93.41% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.70 | 155.40% | ๐บ๐ธ USA |
Teleflex TFX | 2.20 | -16.16% | ๐บ๐ธ USA |
Integra LifeSciences IART | 1.57 | -40.32% | ๐บ๐ธ USA |
Smith & Nephew
SNN | 2.01 | -23.23% | ๐ฌ๐ง UK |